Sexual Health

Sexual difficulties may begin early in a person's life or they may develop after an individual has previously experienced enjoyable and satisfying sex. A problem may develop gradually over time, or may occur suddenly as a total or partial inability to participate in one or more stages of the sexual act.

The World Health Organization defines sexual health as a state of physical, emotional, mental and social well-being in relation to sexuality; it is not merely the absence of disease, dysfunction or infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, discrimination and violence.

What causes Sexual Problems?

The causes of sexual difficulties can be physical, psychological, or both.

Emotional factors affecting sex include both interpersonal problems and psychological problems within the individual. Interpersonal problems include marital or relationship problems, or lack of trust and open communication between partners. Personal psychological problems include depression, sexual fears or guilt, or past sexual trauma.

Physical factors contributing to sexual problems include:

Sexual dysfunctions are more common in the early adult years, with the majority of people seeking care for such conditions during their late 20s through 30s. The incidence increases again in the geriatric population, typically with gradual onset of symptoms that are associated most commonly with medical causes of sexual dysfunction.

Sexual dysfunction is more common in people who abuse alcohol and drugs. It is also more likely in people suffering from diabetes and degenerative neurological disorders. Ongoing psychological problems, difficulty maintaining relationships, or chronic disharmony with the current sexual partner may also interfere with sexual function.

Types of Sexual Problems

Sexual dysfunction disorders are generally classified into 4 categories:
  • sexual desire disorders
  • sexual arousal disorders
  • orgasm disorders, and
  • sexual pain disorders.

Sexual desire disorders (decreased libido) may be caused by a decrease in the normal production of estrogen (in women) or testosterone (in both men and women). Other causes may be aging, fatigue, pregnancy, and medications -- the SSRI anti-depressants which include fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil) are well known for reducing desire in both men and women. Psychiatric conditions, such as depression and anxiety, can also cause decreased libido.

Sexual arousal disorders were previously known as frigidity in women and impotence in men. These have now been replaced with less judgmental terms. Impotence is now known as erectile dysfunction, and frigidity is now described as female sexual dysfunction, a term that covers a range of several specific problems with desire, arousal, or anxiety.

For both men and women, these conditions may appear as an aversion to, and avoidance of, sexual contact with a partner. In men, there may be partial or complete failure to attain or maintain an erection, or a lack of sexual excitement and pleasure in sexual activity.

There may be medical causes for these disorders, such as decreased blood flow or lack of vaginal lubrication. Chronic disease may also contribute to these difficulties, as well as the nature of the relationship between partners. As the success of Viagra attests, many erectile disorders in men may be primarily physical, not psychological conditions.

Orgasm disorders are a persistent delay or absence of orgasm following a normal sexual excitement phase. The disorder occurs in both women and men. Again, the SSRI antidepressants are frequent culprits -- these may delay the achievement of orgasm or eliminate it entirely.

Sexual pain disorders affect women almost exclusively, and are known as dyspareunia (painful intercourse) and vaginismus (an involuntary spasm of the muscles of the vaginal wall, which interferes with intercourse). Dyspareunia may be caused by insufficient lubrication (vaginal dryness) in women.

Poor lubrication may result from insufficient excitement and stimulation, or from hormonal changes caused by menopause, pregnancy, or breast-feeding. Irritation from contraceptive creams and foams may also cause dryness, as can fear and anxiety about sex.

It is unclear exactly what causes vaginismus, but it is thought that past sexual trauma such as rape or abuse may play a role. Another female sexual pain disorder is called vulvodynia or vulvar vestibulitis. In this condition, women experience burning pain during sex which may be related to problems with the skin in the vulvar and vaginal areas. The cause is unknown.

Symptoms

  • Men or women:
    • Lack of interest in sex (loss of libido)
    • Inability to feel aroused
    • Pain with intercourse (much less common in men than women)
  • Men :
    • Inability to attain an erection
    • Inability to maintain an erection adequately for intercourse
    • Delay or absence of ejaculation, despite adequate stimulation
    • Inability to control timing of ejaculation
  • Women:
    • Inability to relax vaginal muscles enough to allow intercourse
    • Inadequate vaginal lubrication before and during intercourse
    • Inability to attain orgasm
    • Burning pain on the vulva or in the vagina with contact to those areas

Diagnosis

Specific physical findings and testing procedures depend on the form of sexual dysfunction being investigated. A complete history is usually taken and a physical examination performed to:

  • Identify predisposing illnesses or conditions
  • Highlight possible fears, anxieties, or guilt specific to sexual behaviors or performance
  • Uncover any history of prior sexual trauma

A physical examination of both the partners should include the whole body and not be limited to the reproductive system.

Call your doctor if:

Call for an appointment with your health care provider if sexual problems persist and are a concern.

Treatment Options

Treatment depends on the cause of the sexual dysfunction. Medical causes that are reversible or treatable are usually managed medically or surgically. Physical therapy and mechanical aides may prove helpful for some people experiencing sexual dysfunction due to physical illnesses, conditions, or disabilities.

For men who have difficulty attaining an erection, the phosphodiesterase type 5 inhibitors (PDE-5 inhibitors) such as sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra, Staxyn) are commonly used for erectile dysfunction. PDE-5 inhibitors increase blood flow to the penis, and can be taken 1/2 to 4 hours prior to intercourse. Cialis can be given on a daily basis without regard for sexual activity timing, but it is given at a lower dose.

Men who take nitrates for coronary heart disease should not take PDE-5 inhibitors. Mechanical aids and penile implants are also an option for men who cannot attain an erection and who find that PDE-5 inhibitors are not helpful.

Read More: Agents Used in the Treatment of Impotence

Women with vaginal dryness may be helped with lubricating gels, hormone creams, and -- in cases of premenopausal or menopausal women -- with hormone replacement therapy. In some cases, women with androgen deficiency can be helped by taking testosterone.

Vulvodynia can be treated with testosterone cream, with use of biofeedback, and with low doses of some antidepressants, which also treat nerve pain. Surgery has not been successful.

Ospemifene
 (Osphena)
 is
 a medication approved on February 26, 2013 for painful sex in women (dyspareunia). Ospemifene is an
 oral
 selective
 estrogen
 receptor
 modulator
 (SERM),
 with
 tissue‐specific
 estrogenic
 agonist/antagonist 
effects.
 Basically, ospemifene acts on some tissues like an estrogen and on other tissues like an anti-estrogen. Other drugs on the U.S. market that are in the same class include tamoxifen, toremifene, and raloxifene, but they do not work specifically on vaginal tissues. Vaginal tissues and linings may thin just prior to, or during menopause. Vaginal secretions may decline making sex very painful. Topical estrogen treatments, such as topical cream, tablet, or the vaginal ring have been used effectively for this condition. Ospemifene
 is
 the
 first
 non‐estrogen
 treatment
 approved 
for 
moderate-
to-severe 
dyspareunia 
in 
women
 with 
menopause‐related 
vulvar
 and 
vaginal 
atrophy.
 However, ospemifene may increase the risk of developing endometrial hyperplasia, a condition that may lead to cancer of the uterus. If a women's uterus has not been removed, her doctor may prescribe a progestin to use while taking ospemifene.

Behavioral treatments involve many different techniques to treat problems associated with orgasm and sexual arousal disorders. Self-stimulation and the Masters and Johnson treatment strategies are among the many behavioral therapies used.

Simple, open, accurate, and supportive education about sex and sexual behaviors or responses may be all that is required in many cases. Some couples may benefit from joint counseling to address interpersonal issues and communication styles. Psychotherapy may be required to address anxieties, fears, inhibitions, or poor body image.

Prevention

Open, informative, and accurate communication regarding sexual issues and body image between parents and their children may prevent children from developing anxiety or guilt about sex and may help them develop healthy sexual relationships.

Review all medications, both prescription and over-the-counter, for possible side effects that relate to sexual dysfunction. Avoiding drug and alcohol abuse will also help prevent sexual dysfunction.

Couples who are open and honest about their sexual preferences and feelings are more likely to avoid some sexual dysfunction. One partner should, ideally, be able to communicate desires and preferences to the other partner.

People who are victims of sexual trauma, such as sexual abuse or rape at any age, are urged to seek psychiatric advice. Individual counseling with an expert in trauma may prove beneficial in allowing sexual abuse victims to overcome sexual difficulties and enjoy voluntary sexual experiences with a chosen partner.

See Also:

    References

  • The World Health Organization (WHO). Sexual and Reproductive Health. Defining sexual health. Accessed February 25, 2014 at http://www.who.int/reproductivehealth/topics/sexual_health/sh_definitions/en/
  • Elkinson 
S,
Yang
 LP
. Ospemifene: 
first
 global 
approval.
 Drugs 2013. 73:605‐12. 
doi:
10.1007/s40265‐013‐0046‐y.

Last updated: 2014-05-04 by L. Anderson, PharmD

Hide
(web3)